Cargando…

L’érythroblastopénie et la myélofibrose primitive: association très rare (à propos d’un cas)

The combination of erythroblastopenia and primary myelofibrosis is very rare. We here report the unusual case of a 76-year-old Moroccan patient followed up since 2018 for idiopathic erythroblastopenia, initially treated with corticotherapy and then with ciclosporin. Two years later, the patient repo...

Descripción completa

Detalles Bibliográficos
Autores principales: EL Maachi, Nora, El Mehdi, Mahtat, Filali, Imane Ait, Jennane, Selim, El Maaroufi, Hicham, Doghmi, Kamal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547022/
https://www.ncbi.nlm.nih.gov/pubmed/36284568
http://dx.doi.org/10.11604/pamj.2022.42.201.32754
Descripción
Sumario:The combination of erythroblastopenia and primary myelofibrosis is very rare. We here report the unusual case of a 76-year-old Moroccan patient followed up since 2018 for idiopathic erythroblastopenia, initially treated with corticotherapy and then with ciclosporin. Two years later, the patient reported bone pain with splenomegaly. Assessment including myelogram, bone marrow biopsy and molecular biology showed myelofibrosis. Etiological assessment of myelofibrosis was negative confirming its primitive nature. The patient received ruxolitinib with transfusion support. Patient´s outcome was favorable and marked by improvement of general condition, splenomegaly and transfusion rate. The association between erythroblastopenia and myeloproliferative disorder is exceptional and only a few cases have been reported in the literature.